Litcius/Paper detail

Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant

Wanbo Tai, Benjie Chai, Shengyong Feng, Xinyu Zhuang, Jun Ma, Mujia Pang, Lin Pan, Zi Yang, Mingyao Tian, Gong Cheng

2022Signal Transduction and Targeted Therapy29 citationsDOIOpen Access PDF

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologyFerritin2019-20 coronavirus outbreakNanoparticleComputational biologyBiologyMedicineNanotechnologyMaterials scienceBiochemistryInfectious disease (medical specialty)PathologyDiseaseOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant | Litcius